IL6 and neoplasm: Additionally, CD300E significantly enhances pathways such as TNF-α signaling, inflammatory response pathways, IL6-JAK signaling, and epithelial-mesenchymal transition (EMT), all of which are documented to potentially promote tumor growth and metastasis (Figure 6).